Dendreon shares Left for Dead?
There are the crazy price targets such as $18 by Maxim Group set in September and more reasonable $7 from Baird back in August. Going with BofA would represent a 44% increase to get back to $6 from today's price. Take a look at the crack price tp of $18, a 300%+ increase in the next 12 months...really?
|Ticker||Current Price||Target Price||% Increase|
Dendreon reports Q3 earnings at the end of the month on October 30th. Expect the stock to tread water until we hear something at that time. What could work for playing the conference call is a covered call on DNDN to protect your neck.
MASTERY Bottom line:
Provenge has a bunch of competition and when it costs $100K per patient, its not going to everyone who could really benefit from it.
Medivation (MDVN) and Astellas Pharma (ALPMY.PK) are getting ready to take on Provenge with their prostate cancer fighting drug Xtandi. There is room in the prostate cancer arena, these drugs are used at different stages of treating prostate cancer. Johnson & Johnson's (JNJ) Zytiga is also competing in this space as is Jevtana from Sanofi. The prostate cancer treatment field is getting crowded, its why DNDN has tanked to $4.
However Dendreon isn't dead yet. The stock can go lower but at $4 its worth a few bucks to go long.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- Gauging the Height of the Bounce | iBankCoin.com
- Despite 'Record' Opening Weekend, Goldman Fears "The iPhone Effect" On Retail Sales May Disappoint | ZeroHedge
- Presenting The Two-Tier Market: Mapping Europe's Microwave Tower Network | ZeroHedge
- The US Ponzi Economy | ZeroHedge
- Martin Armstrong: Capital Herding Into the U.S., Likely to Push Dollar, Stocks Higher Into Next Year | Financial Sense
- Chart Of The Day: 150 Years Of Global Monetary Policy | ZeroHedge
- OPEC Hints It May Act to Stop Oil Price Slide | Financial Sense
The most relevant financial news and articles from the Internets
- The 10 Most Important Things In The World Right Now | Business Insider
- Millennials Are Getting Something Very Right About Money And Happiness | Business Insider
- LINKEDIN DEMOGRAPHICS: The Top Statistics That Make The Network's... | Business Insider
- Putin Is Getting Most Of What He Wants In Ukraine | Business Insider
- Why the Rockefellers May Be Right in Ditching Energy Stocks | TheStreet.com
- Laptop Computer Reviews - BusinessWeek | BusinessWeek
- Step Inside Bernie Madoff's $14.5 Million Penthouse Where The Ponzi Schemer... | Business Insider